Adynovate recombinant and Diethylpropion Controlled-Release Tablets
Determining the interaction of Adynovate recombinant and Diethylpropion Controlled-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Adynovate (recombinant)
Generic Name: diethylpropion
Brand name: Tenuate, Tenuate Dospan
Synonyms: Diethylpropion
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Adynovate recombinant-Diethylpropion Extended Release
- Adynovate recombinant-Diethylpropion Hydrochloride
- Adynovate recombinant-Diethylpropion Tablets
- Adynovate recombinant-Difenoxin and Atropine
- Adynovate recombinant-Differin
- Adynovate recombinant-Differin (Adapalene)
- Diethylpropion Controlled-Release Tablets-Adzenys ER
- Diethylpropion Controlled-Release Tablets-Adzenys ER Oral Suspension
- Diethylpropion Controlled-Release Tablets-Adzenys XR-ODT
- Diethylpropion Controlled-Release Tablets-Aemcolo
- Diethylpropion Controlled-Release Tablets-Aerobid
- Diethylpropion Controlled-Release Tablets-Aerobid-M